Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
40.19B | 32.07B | 31.24B | 28.06B | 22.01B | Gross Profit |
6.74B | 4.77B | 4.84B | 5.11B | 3.83B | EBIT |
2.16B | 532.59M | 692.41M | 1.52B | 625.76M | EBITDA |
2.42B | 757.87M | 878.89M | 1.67B | 782.06M | Net Income Common Stockholders |
1.44B | 221.77M | 327.26M | 960.02M | 349.50M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
5.36B | 3.39B | 2.97B | 3.38B | 2.60B | Total Assets |
28.86B | 25.40B | 24.22B | 22.56B | 16.02B | Total Debt |
16.64B | 16.20B | 16.04B | 12.92B | 9.94B | Net Debt |
11.29B | 12.81B | 13.06B | 9.53B | 7.35B | Total Liabilities |
23.19B | 21.05B | 19.97B | 18.63B | 13.73B | Stockholders Equity |
5.66B | 4.36B | 4.25B | 3.93B | 2.30B |
Cash Flow | Free Cash Flow | |||
1.71B | 427.10M | -3.46B | -2.74B | -70.00M | Operating Cash Flow |
1.95B | 608.03M | -3.07B | -2.46B | 162.15M | Investing Cash Flow |
-323.54M | -213.72M | -468.08M | -379.38M | -290.87M | Financing Cash Flow |
289.64M | 18.37M | 3.10B | 3.62B | 444.01M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥7.89B | 5.42 | 3.07% | 25.30% | 548.48% | ||
61 Neutral | $2.83B | 10.92 | 0.41% | 8438.90% | 5.75% | -21.03% | |
€35.73M | 7.33 | 4.51% | 5.07% | ― | ― | ||
81 Outperform | ¥9.71B | 6.91 | 2.28% | 18.93% | 77.54% | ||
59 Neutral | ¥5.72B | 8.32 | 4.48% | 4.11% | -54.07% | ||
59 Neutral | ¥15.04B | 27.94 | 1.08% | 101.05% | <0.01% | ||
50 Neutral | ¥5.95B | ― | ― | -21.82% | -93.99% |